South Korea's Lotte Group has completed the construction of its first biopharmaceutical plant in Songdo, Incheon, further scaling up its biopharmaceutical business.
South Korea's Lotte Group held a completion ceremony on Wednesday (November 18) for its first biopharmaceutical manufacturing plant in Songdo, Incheon, as part of efforts to diversify its business beyond traditional retail, food, and chemicals. Lotte Group Chairman Shin Dong-bin stated at the ceremony that the biopharmaceutical business is a future growth engine for the group and will spearhead South Korea's next-generation industry.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Samsung Electronics rose 4.05% from its previous close and is currently trading at ₩198,000.
-
2
SK Hynix rose 5.01% from its previous close, currently trading at ₩1,153,000.
-
3
NEAR (NEAR Protocol) surged 6.1% in 4 hours, currently trading at $3.358
-
4
SK Hynix rose 6.56% from its previous close, currently trading at ₩1,170,000.
-
5
US airlines, Microsoft, banks, the NSA, and Apple have suffered consecutive outages, with varying causes and recovery progress
-
6
CNBC: Japan's October Exports Up 20.5% YoY, Semiconductor Equipment Shipments Surge 49.7%
-
7
SCMP: Hang Lung Properties Completes HK$998M Land Premium for 37 Shouson Hill Road Project
-
8
UBS expects the renminbi to strengthen to 6.25 per US dollar by the end of 2027.
-
9
CryptoSlate: Developers report 72-second Bitcoin UTXO snapshot verification experiment, not yet full node validation
-
10
CryptoSlate: PEAR Team Reports Simulated Post-Training Model Succeeds 18 Out of 30 Times in Embodied Robotics Tests
Markets Today
Recommended Reading


